Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes
1. In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...
1. In patients with type 2 diabetes (T2D), the risk of major adverse cardiovascular events (MACEs) was lowest among patients ...
1. In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval in the United States ...
Click here to read the study in Annals of Internal Medicine ©2025 2 Minute Medicine, Inc. All rights ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.